Lidoflazine is a drug used to treat high blood pressure and angina (chest pain). It works by blocking certain chemicals in the body that cause the blood vessels to constrict, which helps reduce blood pressure and improve blood flow to the heart. It is also sometimes prescribed to help reduce the risk of developing certain heart conditions, such as heart attack and stroke.
While Lidoflazine shares a similar name to Lidocaine, it's crucial to understand that they are distinct medications with different uses and properties. Here's a breakdown of Lidoflazine:
Important Notice:
- Lidoflazine is not widely available and its use is generally not recommended due to safety concerns and the existence of alternative medications with better efficacy and safety profiles.
Historical Context:
- Lidoflazine was previously investigated as a potential treatment for:
- Angina pectoris (chest pain caused by reduced blood flow to the heart)
- Cardiac arrhythmias (irregular heartbeats)
Properties:
- Category: Lidoflazine belonged to the class of calcium channel blockers.
- Mechanism of Action: These medications work by blocking calcium ions from entering certain types of heart muscle cells, leading to relaxation of blood vessels and potentially improved blood flow.
Reasons for Limited Use:
- Safety Concerns: Research indicated that Lidoflazine may cause adverse effects, including:
- QT interval prolongation (a specific measurement on an EKG that can increase the risk of serious heart rhythm problems)
- Other potential side effects like headache, dizziness, and gastrointestinal issues.
- Alternative Treatments: The development of safer and more effective medications for angina and arrhythmias has rendered Lidoflazine a less preferable option.
Current Status:
- Due to the aforementioned safety concerns and the availability of superior alternatives, Lidoflazine is not widely prescribed and its use is generally discouraged.
Anatomical Therapeutic Chemical Classification
C - Cardiovascular system
C08 Calcium channel blockers
C08E - Non-selective calcium channel blockers
C08EA Phenylalkylamine derivatives
ATC Code
External Links
Lidoflazine